Literature DB >> 12607687

Epicardial pulmonary vein isolation by cryoablation as concomitant cardiac operation to treat nonvalvular atrial fibrillation.

Hiroshi Kubota1, Shinichi Takamoto, Tetsuro Morota, Toshiya Ohtsuka, Noboru Motomura, Yutaka Kotsuka, Kenichi Sudo.   

Abstract

Since Haïssagere and colleagues reported that a rapid firing focus in or close to the pulmonary veins could be the cause of atrial fibrillation, a transcutaneous catheter technique directed at isolating these foci has been developed. How should patients with nonvalvular atrial fibrillation who require cardiac operation be managed? We developed an epicardial technique that uses cryoablation to isolate the left atrial posterior wall and pulmonary veins and used it to treat a patient. Because cryoablation is achieved epicardially, the technique does not require atriotomy and does not prolong aortic cross-clamp time. Isolation of the left atrium was confirmed by electrophyscologic studies, and the patient remains in sinus rhythm 16 months after operation. This concomitant procedure allows treatment of patients with nonvalvular atrial fibrillation.

Entities:  

Mesh:

Year:  2003        PMID: 12607687     DOI: 10.1016/s0003-4975(02)04275-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Easy pulmonary vein isolation using epicardial cryoablation.

Authors:  Yoshitsugu Nakamura; Kiyoharu Nakano; Hayao Nakatani; Akihiko Gomi; Atsuhiko Sato; Koichi Sughimoto
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Laser Ablation Of Atrial Fibrillation: Mid-term Clinical Experience.

Authors:  Li Poa; Miguel Puig; Pablo Zubiate; Edward Ranzenbach; Miller Shari-Knutson; Christina Poa; Hyunah Poa
Journal:  J Atr Fibrillation       Date:  2009-08-01

3.  Epicardial microwave application in chronic atrial fibrillation surgery.

Authors:  Sang Kwon Lee; Suk Jung Choo; Kyung Sun Kim; Jae Won Lee
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.